Fate of dietary tryptophan in young Japanese women

International Journal of Tryptophan Research

Volumn 5, Issue 1, 2013, Pages 33-47

  Hiratsuka, Chiaki ^a   Fukuwatari, Tsutomu ^a   Shibata, Katsumi ^a  

^a UNIVERSITY OF SHIGA PREFECTURE   (Japan)

Author keywords

Fate; HPLC; Japanese; Tryptophan; Urine

Indexed keywords

EID: 84877910527     PISSN: None     EISSN: 11786469     Source Type: Journal    
DOI: 10.4137/IJTR.S10497     Document Type: Article

References (59)

1. Mahan DC, Shields RG. Essential and nonessential amino acid composition of pigs from birth to 145 kilograms of body weight, and comparison to other studies. J Anim Sci. 1998;76:513-21.
2. Ministry of Health, Labour and Welfare of Japan (2010) Dietary Reference Intake for Japanese. 2010; Daiichi Shuppan Publishing Co, Ltd: Tokyo.
3. Rosen F, Huff JW, Perlzweig WA. The effect of tryptophan on the synthesis of nicotinic acid in the rat. J Biol Chem. 1946;163:343-4.
4. Heiderberger C, Abraham EP, Leprovsky S. Tryptophan metabolism; concerning the mechanism of the mammalian conversion of tryptophan into nicotinic acid. J Biol Chem. 1949;179:151-5.
5. Hilmas C, Pereira EFR, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci. 2001;21:7463-73.
6. Schwarcz R, Guidetti P, Sathyasaikumar KV, Muchowski PJ. Of mice, rats and men: Revising the quinolinic acid hypothesis of Huntington's disease Prog Neurobiol. 2010;90:230-45.
7. Schwarcz R, Whetsell WO Jr, Mangano RM. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science. 1983;219:316-8.
8. Nishizawa S, Benkelfat C, Young SN, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A. 1997;94:5308-13.
9. Turvill JL, Connor P, Farthing MJ. The inhibition of cholera toxin-induced 5-HT release by the 5-HT(3) receptor antagonist, granisetron, in the rat. Br J Pharmacol. 2000;130:1031-6.
10. Axelrod J, Shein HM, Wurtman RJ. Stimulation of C14-melatonin synthesis from C14-tryptophan by noradrenaline in rat pineal in organ culture. Proc Natl Acd Sci U S A. 1969;62:544-9.
11. Leklem JE, Woodford J, Brown RR. Comparative tryptophan metabolism in cats and rats: differences in adaptation of tryptophan oxygenase and in vivo metabolism of tryptophan, kynurenine and hydroxykynurenine. Comp Biochem Physiol. 1969;31:95-109.
12. Sucher R, Kurz K, Weiss G, Margreiter R, Fuchs D, Brandacher G. IDO-mediated tryptophan degradation in the pathogenesis of malignant tumor disease. Int J Tryptophan Res. 2010;3:113-20.
13. Hu B, Hissong BD, Carlin JM. Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes. J Interferon Cytokine Res. 1995;15:617-24.
14. Von Bubnoff D, Scheler M, Wilms H, Fimmers R, Bieber T. Identification of IDO-positive and IDO-negative human dendritic cells after activation by various proinflammatory stimuli. J Immunol. 2011;186:6701-9.
15. Rose DP, Braidman IP. Excretion of tryptophan metabolites as affected by pregnancy, contraceptive steroids, and steroid hormones. Am J Clin Nutr. 1971;24:673-83.
16. Fukuwatari T, Murakami M, Ohta M, et al. Changes in the urinary excretion of the metabolites of the tryptophan-niacin pathway during pregnancy in Japanese women and rats. J Nutr Sci Vitaminol (Tokyo). 2004;50:392-8.
17. Hankes LV, Leklem JE, Brown RR, Mekel RC. Tryptophan metabolism in patients with pellagra: problem of vitamin B 6 enzyme activity and feedback control of tryptophan pyrrolase enzyme. Am J Clin Nutr. 1971;24:730-9.
18. Payne IR, Walsh EM, Whittenburg EJ. Relationship of dietary tryptophan and niacin to tryptophan metabolism in schizophrenics and nonschizophrenics. Am J Clin Nutr. 1974;27:565-71.
19. Shibata K, Taguchi H, Sakakibara Y. Comparison of the urinary excretion of niacin and its metabolites in various mammals. Vitamins. 1989;63:369-72.
20. Shibata K, Kakehi H, Matsuo H. Niacin catabolism in rodents. J Nutr Sci Vitaminol (Tokyo). 1990;36:87-98.
21. Yeh JK, Rown RR. Effects of vitamin B-6 deficiency and tryptophan loading on urinary excretion of tryptophan metabolites in mammals. J Nutr. 1997;107:261-71.
22. Leklem JE. Quantitative aspects of tryptophan metabolism in humans and other species: a review. Am J Clin Nutr. 1971;24:659-72.
23. Wolf H, Price JM, Brown RR, Madsen PO. Studies on tryptophan metabolism in male subjects treated with progestational agents. Scan J Clin Lab Invest. 1970;25:237-49.
24. Fukuwatari T, Shibata K. Effect of nicotinamide administration on the tryptophan-nicotinamide pathway in humans. Int J Vitam Nutr Res. 2007; 77:255-62.
25. Shibata K, Onodera M, Aihara S. High-performance liquid chromatographic measurement of tryptophan in blood, tissues, urine, and foodstuffs with electrochemical and fluorometric detections. Agric Biol Chem. 1991;55:1475-81.
26. Fukuwatari T, Ohta M, Sugimoto E, Sasaki R, Shibata K. Effects of dietary di(2-ethylhexyl)phthalate, a putative endocrine disrupter, on enzyme activities involved in the metabolism of tryptophan to niacin in rats. Biochim Biophys Acta. 2004;1672:67-75.
27. Shibata K, Onodera M. Measurement of 3-anthranilic acid and anthranilic acid in urine by high-performance liquid chromatography. Agric Biol Chem. 1991;55:143-8.
28. Shibata K. Fluorimetric micro-determination of kynurenic acid, as endogenous blocker of neurotoxicity, by high-performance liquid chromatography. J Chromatogr. 1988;430:376-80.
29. Shibata K, Onodera M. High-performance liquid chromatographic determination of 3-hydroxykynurenine with fluorometric detection: comparison of preovulatory phase and postovulatory phase urinary excretion. J Chromatogr. 1991;570:13-8.
30. Shibata K, Onodera M. Simultaneous high-performance liquid chromatographic measurement of xanthurenic acid and 3-hydroxyanthranilic acid in urine. Biosci Biotechnol Biochem. 1992;56:974.
31. Shibata K, Kawada T, Iwai K. Simultaneous micro-determination of nicotinamide and its major metabolites, N1-methyl-2-pyridone-5-carboxamide and N1-methyl-3-pyridone-4-carboxamide, by high-performance liquid chromatography. J Chromatogr. 1988;424:23-8.
32. Shibata K. Ultramicro-determination of N1-methylnicotinamide in urine by high-performance liquid chromatography. Vitamins. 1987;61:599-604.
33. Shibata K, Onodera M, Kawada T, Iwai K. Simultaneous micro-determination of serotonin and 5-hydroxyindole-3-acetic acid with 5-hydroxy-N omega-methyl-tryptamine, as an internal standard, in biological materials by high-performance liquid chromatography with electrochemical detection. J Chromatogr. 1988;430:381-7.
34. Shibata K, Yasui M, Sano M, Fukuwatari T. Fluorometric determination of 2-oxoadipic acid, a common metabolite of tryptophan and lysine, by high-performance liquid chromatography with pre-chemical derivatization. Biosci Biotechnol Biochem. 2011;75:185-7.
35. Pullman ME, Colowick SP. Preparation of 2- and 6-pyridones of N1-methylnicotinamide. J Biol Chem. 154;206:121-7.
36. Sasaki S, Yanagibori R, Amano K. Self-administered diet history questionnaire developed for health education: a relative validation of the test-version by comparison with 3-day diet record in women. J Epidemiol. 1998;8:203-15.
37. Sasaki S, Yanagibori R, Amano K. Validity of a self-administered diet history questionnaire for assessment of sodium and potassium-comparison with single 24-hour urinary excretion. Jpn Circ J. 1998;62: 431-5.
38. Mawatari K, Oshida K, Iinuma F, Watanabe M. Determination of quinolinic acid in human urine by liquid chromatography with fluorimetric detection. Adv Exp Med Biol. 1996;398:697-701.
39. Ohkawa H, Ohishi N, Yagi K. A simple method for micro-determination of flavin in human serum and whole blood by high-performance liquid chromatography. Biochem Int. 1982;4:187-94.
40. Ohkawa H, Ohishi N, Yagi K. New metabolites of riboflavin appear in human urine. J Biol Chem. 1983;258:5623-8.
41. Rybak ME, Pfeiffer CM. Clinical analysis of vitamin B(6): determination of pyridoxal 5'-phosphate and 4-pyridoxic acid in human serum by reversed-phase high-performance liquid chromatography with chlorite postcolumn derivatization. Anal Biochem. 2004;333:336-44.
42. Gregory JF 3rd, Kirk JR. Determination of urinary 4-pyridoxic acid using high performance liquid chromatography. Am J Clin Nutr. 1979;32:879-83.
43. Price JM, Brown RR, Yess N. Testing the functional capacity of the tryptophan-niacin pathway in man by analysis of urinary metabolites. Adv Metab Disord. 1965;2:159-225.
44. Wolf H, Brow RR, Price JM, Madsen PO. Studies of tryptophan metabolism in male subjects treated with female sex hormones. J Clin Endocrinol Metab. 1970;31:397-408.
45. Cheminal R, Echenne B, Bellet H, Duran M. Congenital non-progressive encephalopathy and deafness with intermittent episodes of coma and hyperkynureninuria. J Inher Metab Dis. 1996;19:25-30.
46. Nishimoto Y, Takeuchi F, Shibata Y. Molecular properties of L-kynurenine 3-hydroxylase from rat liver mitochondria. J Biochem. 1977;81:1413-25.
47. Zhao J, Chen H, Ni P, et al. Simultaneous determination of urinary tryptophan, tryptophan-related metabolites and creatinine by high performance liquid chromatography with ultraviolet and fluorimetric detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879:2720-5.
48. Xiang ZY, Tang AG, Ren YP, Zhou QX, Luo XB. Simultaneous determination of serum tryptophan metabolites in patients with systemic lupus erythematosus by high performance liquid chromatography with fluorescence detection. Clin Chem Lab Med. 2010;48:513-7.
49. Ma L, Xu B, Wang W, Deng W, Ding M. Analysis of tryptophan catabolism in HBV patients by HPLC with programmed wavelength ultraviolet detection. Clin Chim Acta. 2009;405:94-6.
50. Donald EA, Bossé TR. The vitamin B6 requirement in oral contraceptive users. II. Assessment by tryptophan metabolites, vitamin B6, and pyridoxic acid levels in urine. Am J Clin Nutr. 1979;32:1024-32.
51. WHO/FAO/UNU. Protein and amino acid requirements in human nutrition. Report of a Joint WHO/FAO/UNU Expert Consultation. WHO Technical Report Series. 2007; Geneva.
52. Payne IR, Walsh EM, Whittenburg JR. Relationship of dietary tryptophan and niacin to tryptophan metabolism in schizophrenics and nonschizophrenics. Am J Clin Nutr. 1974;27:565-71.
53. Ploder M, Spittler A, Schroecksnadel K, et al. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors. Clin Sci (Lond). 2009;116:593-8.
54. Torres MI, Lopez-Casado MA, Lorite P, Rios A. Tryptophan metabolism and indoleamine 2,3-dioxygenase expression in coeliac disease, Clin Exp Immunol. 2007;148:419-24.
55. Payne IR, Lu GH, Meyer K. Relationship of dietary tryptophan and niacin to tryptophan metabolism in alcoholics and nonalcoholics. Am J Clin Nutr. 1974;27:572-9.
56. Manches O, Fernandez MV, Plumas J, Chaperot L, Bhardwaj N. Activation of the noncanonical NF-?B pathway by HIV controls a dendritic cell immunoregulatory phenotype. Proc Natl Acad Sci U S A. 2012;109:14122-7.
57. Tawara I, Shlomchik WD, Jones A, et al. A crucial role for host APCs in the induction of donor CD4+ CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. J Immunol. 2010;185:3866-72.
58. Cuffy MC, Silverio AM, Qin L, et al. Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege. J Immunol. 2007;179:5246-54.
59. Rose DP, Braidman IP. Excretion of tryptophan metabolites as affected by pregnancy, contraceptive steroids, and steroid hormones. Am J Clin Nutr. 1971;24:673-83.